News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Moneymaker? More likely a total failure like the management of INQR. LOL
Well then you know what a stupid people there are. It is also the same every time there Where G. Dab is in always everything goes wrong, year after year.
I would also like to know that you do not hear at all even the email is not answered by InnovaQor.
But maybe there is someone else here on this forum who knows more?
Gerard is a zwindler in my opinion
Perhaps it would be better if this Gerard Dab crap finally disappeared from the scene. At least then no more share investors would fall for it.
Expert Market - says a lot about this Gerard Dab shit.
https://www.otcmarkets.com/stock/INQR/overview
Even the best CEO is of no use to the company as long as this Gerard Dab still has his fingers in the game.
|
Followers
|
73
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2826
|
|
Created
|
11/20/06
|
Type
|
Free
|
| Moderators | |||
InnovaQor is a kind of a pioneer in the domain of creating a social platform for physicians, creating a networking, knowledge sharing, and hiring mechanism along the lines of LinkedIn. There is a global shortfall of 4.3 million doctors, nurses, and other healthcare professionals. Through its platform Curallo.com, InnovaQor primarily targets physician groups, facilities and associations trying to acquire advocacy through the larger governing boards with a member-exclusive discount. The revenue streams of this social media platform would include freemium, premium subscription fees, sponsorship, talent search per individual/ facility, and so on. As LinkedIn has shown, there is a need for additional access, knowledge, and connectivity, which comes with a monthly premium access fee. In fact, LinkedIn’s data indicates that individuals are willing to spend $30, while corporations are willing to pay $60 for such services which means InnovaQor definitely can earn strong revenues from its niche. The Talent Search Subscription program is anticipated to upend the market by utilizing AI for matchmaking based on user profile optimization. The Talent Solutions feature on LinkedIn generates 65% of the company's revenue, displacing market leaders like Monster and Indeed. With InnovaQor/Curallo employing an industry-specific model, TSSP is a boon for healthcare professionals, especailly in todays hiring market. Large pharma would find the platform to be alluring for advertising with an engaged industry audience as well. Thus, this new platform could be a huge revenue catalyst for InnovaQor.
ClinLab is a proprietary Windows-based, Internet and web-enabled laboratory information management system. Designed by medical technologists, ClinLab is scalable from small point-of-care labs to large multi-user, multi-location clinical facilities. ClinLab acts as a data warehouse for lab results and includes reporting, data acquisition, label printing, electronic signoff and provides numerous interface capabilities to a multitude of reference labs and practice systems.
Healthcare Technology Solutions (HTS) Virtual Chief Information Officer (vCIO) services provides one-stop, specialized IT services for healthcare facilities which enhance business operations and encourage sustainable growth. Our services focus on infrastructure-related management and we ensure you maintain a competitive advantage with innovative technology solutions. With HTS's vCIO services, organizations gain access to best-in-class managed IT and cloud solutions without the headaches of supporting an in-house staff.
Qira analytics integrates data across your entire business – streamlining operations that improve services, reporting and financial health.
MEDtuning delivers Personalized Medicine to modern clinical practices. MEDtuning develops revolutionary PhyzioType Systems for DNA-guided management and prescription of drugs used to treat mental illness, pain, heart disease, and diabetes. These systems are designed to provide physicians with an unprecedented capability to select for each patient the safest and most effective drug to achieve treatment goals and enhance patient compliance.
WEST PALM BEACH, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: VMCS), today announced that it became a fully SEC reporting company on September 27, 2022 when its Form 10-12G that was filed on September 7, 2022 became effective.
For more information:
https://www.innovaqor.com/
https://medicalmime.com/
https://healthtechnologysolutions.com/analytics/
https://healthtechnologysolutions.com/vcio-services/
https://clinlabinc.com/
https://www.otcmarkets.com/stock/VMCS/security
AI
